Joe
07-18-2007, 05:21 PM
A commentary in the Journal of Clinical Oncology (JCO) urges researchers to explore an intriguing approach to reduce the dose, and therefore the cost, of oral targeted cancer therapies.
More... (http://www.news-medical.net/?id=27713)
More... (http://www.news-medical.net/?id=27713)